65 related articles for article (PubMed ID: 24906958)
1. Antifibrotic activity of conjugates based on amphiphilic pluronic F68 and hydrophobic pluronic L31 with hyaluronate-endo-β-N-acetylhexosaminidase in pulmonary fibrosis.
Skurikhin EG; Reztsova AM; Ermakova NN; Krupin VA; Pershina OV; Khmelevskaya ES; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN; Reykhard DV; Goldberg VE; Dygai AM
Bull Exp Biol Med; 2014 May; 157(1):5-9. PubMed ID: 24906958
[TBL] [Abstract][Full Text] [Related]
2. Antifibrotic effects of immobilized hyaluronidase in repeated bleomycin-induced lesions of the alveolar epithelium.
Dygai AM; Skurikhin EG; Ermakova NN; Reztsova AM; Pershina OV; Khmelevskaya ES; Krupin VA; Stepanova IE; Reztsova VM; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN
Bull Exp Biol Med; 2013 Aug; 155(4):501-6. PubMed ID: 24143378
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory and antifibrotic effects of a combination of spiperone and immobilized hyaluronidase on partially reversible and irreversible toxic pneumofibrosis.
Skurikhin EG; Ermakova NN; Reztsova AM; Pershina OV; Khmelevskaya ES; Krupin VA; Stepanova IE; Reztsova VM; Reihard DV; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN; Goldberg VE; Dygai AM
Bull Exp Biol Med; 2013 Nov; 156(1):53-8. PubMed ID: 24319728
[TBL] [Abstract][Full Text] [Related]
4. Antifibrotic effect of combined treatment with neuroleptic drug and immobilized hyaluronidase in pulmonary fibrosis.
Dygai AM; Skurikhin EG; Ermakova NN; Pershina OV; Krupin VA; Reztsova AM; Ermolaeva LA; Khmelevskaya ES; Stepanova IE; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN; Goldberg VE; Semiglazova TA
Bull Exp Biol Med; 2013 Jan; 154(3):329-33. PubMed ID: 23484193
[TBL] [Abstract][Full Text] [Related]
5. Antifibrotic activity of hyaluronidase immobilized on polyethylenoxide under conditions of bleomycin-induced pneumofibrosis.
Dygai AM; Skurikhin EG; Ermakova NN; Pershina OV; Krupin VA; Reztsova AM; Ermolaeva LA; Khmelevskaya ES; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN
Bull Exp Biol Med; 2013 Jan; 154(3):388-92. PubMed ID: 23484207
[TBL] [Abstract][Full Text] [Related]
6. Effect of hyaluronate-endo-β-N-acetylhexosaminidase pegylated by electron beam synthesis nanotechnology on the formation of hematological shifts in chronic hepatitis.
Dygai AM; Zyuz'kov GN; Gurto RV; Zhdanov VV; Udut EV; Miroshnichenko LA; Simanina EV; Stavrova LA; Chaikovskii AV; Markova TS; Minakova MY; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN
Bull Exp Biol Med; 2012 Dec; 154(2):278-82. PubMed ID: 23330143
[TBL] [Abstract][Full Text] [Related]
7. WNT/β-catenin signaling induces IL-1β expression by alveolar epithelial cells in pulmonary fibrosis.
Aumiller V; Balsara N; Wilhelm J; Günther A; Königshoff M
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):96-104. PubMed ID: 23526221
[TBL] [Abstract][Full Text] [Related]
8. Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene.
Tran PL; Weinbach J; Opolon P; Linares-Cruz G; Reynes JP; Grégoire A; Kremer E; Durand H; Perricaudet M
J Clin Invest; 1997 Feb; 99(4):608-17. PubMed ID: 9045862
[TBL] [Abstract][Full Text] [Related]
9. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
[TBL] [Abstract][Full Text] [Related]
10. A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice.
Takemasa A; Ishii Y; Fukuda T
Eur Respir J; 2012 Dec; 40(6):1475-82. PubMed ID: 22441751
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycemic effects of hyaluronate-endo-β-N-acetylhexosaminidase immobilized by electron beam synthesis nanotechnology.
Dygai AM; Zyuz'kov GN; Zhdanov VV; Udut EV; Miroshnichenko LA; Khrichkova TJ; Simanina EV; Stavrova LA; Gurto RV; Minakova MY; Chajkovskij AV; Markova TS; Artamonov AV; Bekarev AA; Madonov PG; Kinsht DN
Bull Exp Biol Med; 2012 May; 153(1):94-7. PubMed ID: 22808503
[TBL] [Abstract][Full Text] [Related]
12. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
[TBL] [Abstract][Full Text] [Related]
13. ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis.
Martins V; Valença SS; Farias-Filho FA; Molinaro R; Simões RL; Ferreira TP; e Silva PM; Hogaboam CM; Kunkel SL; Fierro IM; Canetti C; Benjamim CF
J Immunol; 2009 May; 182(9):5374-81. PubMed ID: 19380784
[TBL] [Abstract][Full Text] [Related]
14. Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.
Lin C; Duitman J; Daalhuisen J; Ten Brink M; von der Thüsen J; van der Poll T; Borensztajn K; Spek CA
Thorax; 2014 Feb; 69(2):152-60. PubMed ID: 24029744
[TBL] [Abstract][Full Text] [Related]
15. Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice.
Furonaka M; Hattori N; Tanimoto T; Senoo T; Ishikawa N; Fujitaka K; Haruta Y; Yokoyama A; Kohno N
J Pharmacol Exp Ther; 2009 Jan; 328(1):55-61. PubMed ID: 18832650
[TBL] [Abstract][Full Text] [Related]
16. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
17. Temporal and spatial characterization of mononuclear phagocytes in circulating, lung alveolar and interstitial compartments in a mouse model of bleomycin-induced pulmonary injury.
Ji WJ; Ma YQ; Zhou X; Zhang YD; Lu RY; Sun HY; Guo ZZ; Zhang Z; Li YM; Wei LQ
J Immunol Methods; 2014 Jan; 403(1-2):7-16. PubMed ID: 24280595
[TBL] [Abstract][Full Text] [Related]
18. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice.
Aono Y; Nishioka Y; Inayama M; Ugai M; Kishi J; Uehara H; Izumi K; Sone S
Am J Respir Crit Care Med; 2005 Jun; 171(11):1279-85. PubMed ID: 15735062
[TBL] [Abstract][Full Text] [Related]
19. Early granulocyte-macrophage colony-stimulating factor expression by alveolar inflammatory cells during bleomycin-induced rat lung fibrosis.
Andreutti D; Gabbiani G; Neuville P
Lab Invest; 1998 Dec; 78(12):1493-502. PubMed ID: 9881949
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
